Nuzenio

Adalta Reports All

Adalta Reports All news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Australian company points to encouraging survival signal in mesothelioma CAR-T study - BiotechDispatchBiotechDispatch · Mon, 10 Aug 2026 08:35:18 GMT AdAlta Reports All Five Remaining EW-001 Mesothelioma Patients Still Alive at July 2026 Update - KalkineKalkine · Mon, 10 Aug 2026 02:34:07 GMT AdAlta’s EW-001 CAR-T Shows Promising Survival and Response in Advanced Mesothelioma - TipRanksTipRanks · Sun, 09 Aug 2026 23:48:55 GMT AdAlta reports two year cancer free survival after single dose of experimental mesothelioma therapy - BiotechDispatchBiotechDispatch · Wed, 05 Aug 2026 09:32:35 GMT Health Check: BlinkLab shares surge on breakthrough ADHD detection results - StockheadStockhead · Wed, 05 Aug 2026 02:07:53 GMT AdAlta Reports Two-Year Survival Milestone for First EW-001 Complete Responder in Mesothelioma Study - KalkineKalkine · Wed, 05 Aug 2026 00:55:33 GMT AdAlta (ASX:1AD) Reports Two-Year Cancer-Free Survival Milestone in EW-001 Mesothelioma Study - KalkineKalkine · Wed, 05 Aug 2026 00:17:00 GMT

Timeline

Mon, 10 Aug 2026 08:35:18 GMTAustralian company points to encouraging survival signal in mesothelioma CAR-T study - BiotechDispatch

Mon, 10 Aug 2026 02:34:07 GMTAdAlta Reports All Five Remaining EW-001 Mesothelioma Patients Still Alive at July 2026 Update - Kalkine

Sun, 09 Aug 2026 23:48:55 GMTAdAlta’s EW-001 CAR-T Shows Promising Survival and Response in Advanced Mesothelioma - TipRanks

Wed, 05 Aug 2026 09:32:35 GMTAdAlta reports two year cancer free survival after single dose of experimental mesothelioma therapy - BiotechDispatch

Wed, 05 Aug 2026 02:07:53 GMTHealth Check: BlinkLab shares surge on breakthrough ADHD detection results - Stockhead

Wed, 05 Aug 2026 00:55:33 GMTAdAlta Reports Two-Year Survival Milestone for First EW-001 Complete Responder in Mesothelioma Study - Kalkine

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

CAR4 live mentions AdAlta3 live mentions BiotechDispatch BiotechDispatch2 live mentions Mesothelioma Patients Still2 live mentions Alive2 live mentions July2 live mentions Kalkine AdAlta Reports2 live mentions T Shows Promising2 live mentions Survival2 live mentions Response2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Adalta Reports All.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.